Manfred Mahrle

Angel Investor at Orderlion · Vienna, Austria

Invests in AI

Manfred Mahrle's investor profile lists AI alongside Healthcare & Biotech and Food & Beverage, at early-stage venture. The record holds 5 deals, among them mediaire, B. Braun Austria GmbH and Orderlion.

Email Investor

Email Investor

Credits to line up before an early-stage round

Manfred Mahrle backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • mediaire
  • B. Braun Austria GmbH
  • Orderlion
  • piur imaging GmbH
  • B. Braun Gruppe

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Food & Beverage
Rounds
Early-stage venture
Profile
Angel investor
Deals on record
5
Based in
Vienna, Austria

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Manfred Mahrle invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Manfred Mahrle's investor profile, together with Healthcare & Biotech and Food & Beverage. The stages on record are early-stage venture.
Which companies has Manfred Mahrle backed?
The record lists 5 deals, including mediaire, B. Braun Austria GmbH, Orderlion, piur imaging GmbH and B. Braun Gruppe. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Manfred Mahrle?
For a company raising an early-stage round, AI Perks lists credits such as Oracle (up to $10,000), Weaviate (up to $100,000), Ansys (up to $15,000) and Vercel (up to $850,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor